These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38158939)

  • 21. [Laboratory diagnostics in rheumatology].
    Wiik A
    Ugeskr Laeger; 2002 Jan; 164(5):610-4. PubMed ID: 11871209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Report on the second Asia Autoimmunity Forum 3-5 March 2006, Hong Kong.
    Kavikondala S; Nie YJ; Lau CS
    Autoimmun Rev; 2006 Dec; 6(2):115-8. PubMed ID: 17138255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telerheumatology: A Systematic Review.
    McDougall JA; Ferucci ED; Glover J; Fraenkel L
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1546-1557. PubMed ID: 27863164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innate immunity as the trigger of systemic autoimmune diseases.
    Saferding V; Blüml S
    J Autoimmun; 2020 Jun; 110():102382. PubMed ID: 31883831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-celiac gluten sensitivity and rheumatic diseases.
    Isasi C; Tejerina E; Morán LM
    Reumatol Clin; 2016; 12(1):4-10. PubMed ID: 25956352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moving towards a molecular taxonomy of autoimmune rheumatic diseases.
    Barturen G; Beretta L; Cervera R; Van Vollenhoven R; Alarcón-Riquelme ME
    Nat Rev Rheumatol; 2018 Jan; 14(2):75-93. PubMed ID: 29362467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. γδ T cells in rheumatic diseases: from fundamental mechanisms to autoimmunity.
    Nguyen CT; Maverakis E; Eberl M; Adamopoulos IE
    Semin Immunopathol; 2019 Sep; 41(5):595-605. PubMed ID: 31506867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheumatology.
    Panush RS; Arend WP
    JAMA; 1997 Jun; 277(23):1899-900. PubMed ID: 9185825
    [No Abstract]   [Full Text] [Related]  

  • 29. Autoinflammation and autoimmunity: pathogenic, clinical, diagnostic and therapeutic aspects.
    Perricone C; Toubi E; Valesini G; Shoenfeld Y
    Isr Med Assoc J; 2014 Oct; 16(10):601-4. PubMed ID: 25438441
    [No Abstract]   [Full Text] [Related]  

  • 30. Paediatric rheumatology: a subspecialty in its infancy that is making leaps and bounds.
    Ooi PL; Shek LP
    Singapore Med J; 2014 May; 55(5):242-3. PubMed ID: 24862745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The coexistence of autoimmune rheumatic diseases and thymomas.
    Jiang Y; Dai X; Duan L; Zhou Y
    Adv Clin Exp Med; 2017; 26(2):237-243. PubMed ID: 28791840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases.
    Manolis AS; Tzioufas AG
    Curr Vasc Pharmacol; 2020; 18(6):533-537. PubMed ID: 32693768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Translational research in pediatric rheumatology. Current research approaches to the innate immune system].
    Lippitz K; Waldkirch J; Kessel C; Varga G; Foell D
    Z Rheumatol; 2016 Apr; 75(3):276-83. PubMed ID: 26800663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac manifestations of rheumatic diseases.
    Méndez Eirín E; Suárez Ouréns Y; Guerra Vázquez JL
    Med Clin (Barc); 2021 Jun; 156(12):615-621. PubMed ID: 33836859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune and autoinflammatory diseases with mucocutaneous manifestations: A pediatric rheumatology perspective.
    Koker O; Aktay Ayaz N
    Int J Dermatol; 2023 Jun; 62(6):723-736. PubMed ID: 35843911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The aggregation between AITD with rheumatologic, or dermatologic, autoimmune diseases.
    Fallahi P; Elia G; Ragusa F; Ruffilli I; Camastra S; Giusti C; Paparo SR; Gonnella D; Shoenfeld Y; Ferrari SM; Antonelli A
    Best Pract Res Clin Endocrinol Metab; 2019 Dec; 33(6):101372. PubMed ID: 31932147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic Reprogramming of Innate Immune Cells as a Possible Source of New Therapeutic Approaches in Autoimmunity.
    Mohammadnezhad L; Shekarkar Azgomi M; La Manna MP; Sireci G; Rizzo C; Badami GD; Tamburini B; Dieli F; Guggino G; Caccamo N
    Cells; 2022 May; 11(10):. PubMed ID: 35626700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationships between cancer and autoimmune rheumatic diseases.
    Cappelli LC; Shah AA
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101472. PubMed ID: 32029389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings of the Third Israel-Italy Meeting: Advances in Autoimmunity and Rheumatology, October 23-25, 2013, Tel Aviv, Israel.
    Isr Med Assoc J; 2014 Oct; 16(10):601-68. PubMed ID: 25632511
    [No Abstract]   [Full Text] [Related]  

  • 40. Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
    Shin JI; Lee KH; Joo YH; Lee JM; Jeon J; Jung HJ; Shin M; Cho S; Kim TH; Park S; Jeon BY; Jeong H; Lee K; Kang K; Oh M; Lee H; Lee S; Kwon Y; Oh GH; Kronbichler A
    J Autoimmun; 2019 Sep; 103():102299. PubMed ID: 31326231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.